Humana, private equity firms finalize $1.4B Curo acquisition

merger and acquisition
By combining Kindred and Curo, Humana and two private equity firms plan to create the country's largest hospice provider. (istocksdaily)

Humana and two private equity firms have finalized a $1.4 billion acquisition of hospice provider Curo Health Services, the health insurance giant announced on Wednesday.

The closing came nearly three months after Humana announced it would buy the hospice provider alongside private equity firms TPG Capital and Welsh, Carson, Anderson & Stowe from Thomas H. Lee Partners. The insurer will own a 40% stake in the company.

RELATED: Humana partners with private equity firms to acquire hospice provider for $1.4B

Free Daily Newsletter

Like this story? Subscribe to FierceHealthcare!

The healthcare sector remains in flux as policy, regulation, technology and trends shape the market. FierceHealthcare subscribers rely on our suite of newsletters as their must-read source for the latest news, analysis and data impacting their world. Sign up today to get healthcare news and updates delivered to your inbox and read on the go.

Humana and the firms plan to combine Curo with Kindred at Home, which they acquired earlier this month for $4.1 billion. Under the deal, Kindred’s home health, hospice and community care businesses will be separated into a standalone business, 40% of which is owned by Humana. Over time, Humana will have the option of buying the remaining ownership in the company. The combination would create the largest hospice provider in the country.

The two acquisitions reflect a significant step into postacute care on Humana’s part. Curo operates 245 locations in 22 states, and Kindred has operations in 16 states. Humana said the acquisition will allow it to utilize technology, data and analytics to coordinate care and track clinical outcomes.

Suggested Articles

Maryland-based MedStar Health has agreed to pay $35 million to settle allegations it paid kickbacks to a cardiology group in exchange for referrals.

While UPS didn't say which vaccine it would be using in the project, Reuters confirmed with pharma giant Merck that it is looking at participating.

The Trump administration announced it would allow Medicare Advantage plans to use step therapy. Here's what that means for MA plans and Part B meds.